Procognia combines ingenuity, innovation and state-of-the-art biotechnologies in solutions meeting the biopharmaceutical challenges of tomorrow. An innovative and expert biotechnology company and a leader in ground-breaking glycomics applications, Procognia is positioned at the frontier of glycobiology research for therapeutic applications.
Procognia is continually working at the forefront of glycosylation analytics, developing new, updated approaches for biopharmaceutical analysis. Our experienced scientific team of dedicated, highly qualified biochemists and glycobiologists continuously expand the technics and methods to provide our customers with top notch, up-to-date, high quality analyses.
Stem Cells Research
Procognia applies its unique and proprietary technology platform, the Glycoscope™, for the development of groundbreaking applications in the field of therapeutic stem cells.
Procognia is conducting pioneering stem cell research to study the relations between the glycosylation profiles of mesenchymal stem cells (MSC) and their therapeutic activity. By studying the relations between glycosylation profiles and stem cell characteristics such as in-vivo homing and engraftment, cell-cell interactions, and growth factor secretion, the Procognia R&D team is working to improve the efficiency of stem cell treatment and manufacturing processes.